Literature DB >> 1613703

Brain pathology in systemic lupus erythematosus.

J G Hanly1, N M Walsh, V Sangalang.   

Abstract

Brain pathology was documented in 10 patients with systemic lupus erythematosus (SLE), 7 of whom had clinical neuropsychiatric SLE prior to death. This was manifested by seizures (5 patients), organic brain syndrome (3 patients) and psychosis (2 patients). Multifocal cerebral cortical microinfarcts, associated with microvascular injury, were documented in 4 patients and in our study constituted the predominant histopathologic abnormality attributable to SLE. Changes of a healed vasculitis in medium sized leptomeningeal vessels were seen in 1 case. Agreement between the clinical and pathologic classification of neuropsychiatric SLE was observed in 7/10 (70%) cases and the strongest association was between the presence of cerebral microinfarcts and seizures (4/5 patients, p less than 0.05). No correlation was observed with anticardiolipin, anti-P, lymphocytotoxic and antineuronal antibodies.

Entities:  

Mesh:

Year:  1992        PMID: 1613703

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  47 in total

Review 1.  Neuropsychiatric lupus.

Authors:  J G Hanly
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

2.  Cerebral leucocyte infiltration in lupus-prone MRL/MpJ-fas lpr mice--roles of intercellular adhesion molecule-1 and P-selectin.

Authors:  W G James; P Hutchinson; D C Bullard; M J Hickey
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

3.  Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus.

Authors:  Gerlof P Th Bosma; Tom W J Huizinga; Simon P Mooijaart; Mark A Van Buchem
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

Review 4.  Cognitive Impairment in SLE: Mechanisms and Therapeutic Approaches.

Authors:  Aida Zarfeshani; Kaitlin R Carroll; Bruce T Volpe; Betty Diamond
Journal:  Curr Rheumatol Rep       Date:  2021-03-29       Impact factor: 4.592

5.  Improvement of irregularity of brain vessel walls in systemic lupus erythematosus by tacrolimus.

Authors:  Hiromi Kizu; Hiroaki Dobashi; Tomohiro Kameda; Kentaro Susaki; Masahiko Kawanishi; Toshihiko Ishida
Journal:  Clin Rheumatol       Date:  2010-11-04       Impact factor: 2.980

6.  Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center.

Authors:  Melissa Padovan; Gabriella Castellino; Alessandra Bortoluzzi; Luisa Caniatti; Francesco Trotta; Marcello Govoni
Journal:  Rheumatol Int       Date:  2010-07-31       Impact factor: 2.631

7.  Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus.

Authors:  Yasuhiro Shimojima; Masayuki Matsuda; Takahisa Gono; Wataru Ishii; Shu-ichi Ikeda
Journal:  Clin Rheumatol       Date:  2005-03-02       Impact factor: 2.980

8.  Evaluation of the effects of methylprednisolone pulse therapy in patients with systemic lupus erythematosus with brain involvement by Tc-99m HMPAO brain SPECT.

Authors:  S S Sun; W S Huang; J J H Chen; C P Chang; C H Kao; J J Wang
Journal:  Eur Radiol       Date:  2003-12-09       Impact factor: 5.315

9.  Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus.

Authors:  Wilmer L Sibbitt; William M Brooks; Mario Kornfeld; Blaine L Hart; Arthur D Bankhurst; Carlos A Roldan
Journal:  Semin Arthritis Rheum       Date:  2009-10-31       Impact factor: 5.532

Review 10.  Neurologic manifestations of systemic lupus erythematosus in children and adults.

Authors:  Eyal Muscal; Robin L Brey
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.